Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase.

M G Isaguliants1, K Pokrovskaya, V I Kashuba

  • 1D.I. Ivanovsky Institute of Virology, Moscow, Russia. maria.isaguliants@solna.mail.telia.com

FEBS Letters
|April 24, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.

Scientific reports·2018
Same author

HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.

Heliyon·2017
Same author

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses.

Human vaccines & immunotherapeutics·2017
Same author

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children.

Journal of virus eradication·2016
Same author

Predictive performance of telenursing complaints in influenza surveillance: a prospective cohort study in Sweden.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
Same author

Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.

Vaccine·2011

We developed a eukaryotic expression vector for the human immunodeficiency virus type I (HIV-1) reverse transcriptase 66 kDa subunit. This approach successfully generated HIV-1 reverse transcriptase expression in cells and elicited immune responses in vivo.

Area of Science:

  • Molecular Biology
  • Virology
  • Immunology

Background:

  • Human immunodeficiency virus type I (HIV-1) reverse transcriptase is crucial for viral replication.
  • Targeting HIV-1 reverse transcriptase is a key strategy for antiviral therapies.
  • Developing effective expression systems for viral proteins is essential for research and therapeutic development.

Purpose of the Study:

  • To design a eukaryotic expression vector for the 66 kDa subunit of HIV-1 reverse transcriptase.
  • To assess the expression and localization of HIV-1 reverse transcriptase in transfected cells.
  • To evaluate the in vivo immunogenicity of the expressed HIV-1 reverse transcriptase subunit.

Main Methods:

  • Construction of a eukaryotic expression vector utilizing the cytomegalovirus promoter.

Related Experiment Videos

  • Transient transfection of various cell lines with the designed vector.
  • Immunostaining to determine the subcellular localization of the expressed protein.
  • Assay of reverse transcriptase activity in transfected cells.
  • DNA immunization of mice to assess in vivo immune responses.

    • Main Results:

    • Efficient transient expression of the HIV-1 reverse transcriptase 66 kDa subunit was achieved in multiple cell types.
    • Immunostaining confirmed the cytoplasmic localization of the expressed reverse transcriptase.
    • Detectable reverse transcriptase activity was observed in all transfected cell lines.
    • DNA immunization in mice induced significant reverse transcriptase-specific immune responses.
    • Sera from immunized mice demonstrated in vitro inhibition of reverse transcription.

    Conclusions:

    • The designed eukaryotic expression vector enables efficient production of HIV-1 reverse transcriptase 66 kDa subunit.
    • The expressed protein is biologically active and localized in the cytoplasm.
    • In vivo expression and immunogenicity of the HIV-1 reverse transcriptase subunit were confirmed.
    • This system holds potential for further studies on HIV-1 replication and vaccine development.